American Century Companies Inc Neuro Pace Inc Transaction History

American Century Companies Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.29 - $3.67 $416,977 - $1.19 Million	-323,238 Reduced 81.68%	72,508 $108,000
Q3 2022 Nov 14, 2022	SELL	$3.1 - $5.98 $549,977 - $1.06 Million	-177,412 Reduced 30.95%	395,746 $1.48 Million
Q2 2022 Aug 12, 2022	BUY	$4.95 - $8.7 $190,545 - $334,897	38,494 Added 7.2%	573,158 $2.84 Million
Q1 2022 May 11, 2022	BUY	$7.06 - $11.57 $804 - $1,318	114 Added 0.02%	534,664 $4.39 Million
Q4 2021 Feb 07, 2022	BUY	$8.63 - $17.36 $149,799 - $301,334	17,358 Added 3.36%	534,550 $5.39 Million
Q3 2021 Nov 10, 2021	BUY	$15.85 - $25.07 $1.81 Million - $2.87 Million	114,438 Added 28.41%	517,192 $8.2 Million
Q2 2021 Aug 05, 2021	BUY	$19.03 - $26.5 $7.66 Million - $10.7 Million	402,754 New	402,754 $9.58 Million

21.3M

1.3K

100

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $230M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.